Moreover, failing autophagy (Nixon, 2013) predisposes to amyloidosis, which in turn sets the stage for microglial activation/phenotype change, increased CNS inflammation, and microglial toxicity, as well as an emerging tauopathy (modification of tau via excessive phosphorylation or disruption of phosphatase/kinase balance). Here, MAPT is linked to amyloidosis.